Agree still think it's dragging the feet to be on own estimates seeing 2-3 years before it has drug candidates at pre-clinical stage - that's a very long tail. They really need to be pulling in deals or partnerships that put forward significant up-fronts or early stage licensing with near term milestones above penny's - that's what will crack the whip. Delivery of other company's drugs through EET probably the most lucrative if they stumble across them ? Deals with equity stakes at significant premium likewise.
PYC Price at posting:
1.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)